Kory D. Johnson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kory D. Johnson has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Jitka Polechová
University of Vienna
4 shared publications - Annemarie Grass
University of Vienna
3 shared publications Mathias Beiglböck
Faculty of Mathematics, University of Vienna, Austria
3 shared publications- Mathias Beiglböck
University of Vienna, Austria
3 shared publications Alex Crozier
Division of Biosciences, University College London, London, UK
2 shared publicationsDaniel Toneian
Department of Mathematics University of Vienna Vienna Austria
2 shared publications
Latest Publications
- Open Access
- 9 May 2022
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (5) , e0000412
Robust models of disease heterogeneity and control, with application to the SARS-CoV-2 epidemic
In light of the continuing emergence of new SARS-CoV-2 variants and vaccines, we create a robust simulation framework for exploring possible infection trajectories under various scenarios. The situations of primary interest involve the interaction between three components: vaccination campaigns, non-pharmaceutical interventions (NPIs), and the emergence of new SARS-CoV-2 variants. Additionally, immunity waning and vaccine boosters are modeled to account for their growing importance. New infections are generated according to a hierarchical model in which people have a random, individual infectiousness. The model thus includes super-spreading observed in the COVID-19 pandemic which is important for accurate uncertainty prediction. Our simulation functions as a dynamic compartment model in which an individual’s history of infection, vaccination, and possible reinfection all play a role in their resistance to further infections. We present a risk measure for each SARS-CoV-2 variant, , that accounts for the amount of resistance within a population and show how this risk changes as the vaccination rate increases. highlights that different variants may become dominant in different countries—and in different times—depending on the population compositions in terms of previous infections and vaccinations. We compare the efficacy of control strategies which act to both suppress COVID-19 outbreaks and relax restrictions when possible. We demonstrate that a controller that responds to the effective reproduction number in addition to case numbers is more efficient and effective in controlling new waves than monitoring case numbers alone. This not only reduces the median total infections and peak quarantine cases, but also controls outbreaks much more reliably: such a controller entirely prevents rare but large outbreaks. This is important as the majority of public discussions about efficient control of the epidemic have so far focused primarily on thresholds for case numbers.- 9 May 2022
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (5) , e0000412
Open AccessRobust models of disease heterogeneity and control, with application to the SARS-CoV-2 epidemic
In light of the continuing emergence of new SARS-CoV-2 variants and vaccines, we create a robust simulation framework for exploring possible infection trajectories under various scenarios. The situations of primary interest involve the interaction between three components: vaccination campaigns, non-pharmaceutical interventions (NPIs), and the emergence of new SARS-CoV-2 variants. Additionally, immunity waning and vaccine boosters are modeled to account for their growing importance. New infections are generated according to a hierarchical model in which people have a random, individual infectiousness. The model thus includes super-spreading observed in the COVID-19 pandemic which is important for accurate uncertainty prediction. Our simulation functions as a dynamic compartment model in which an individual’s history of infection, vaccination, and possible reinfection all play a role in their resistance to further infections. We present a risk measure for each SARS-CoV-2 variant, , that accounts for the amount of resistance within a population and show how this risk changes as the vaccination rate increases. highlights that different variants may become dominant in different countries—and in different times—depending on the population compositions in terms of previous infections and vaccinations. We compare the efficacy of control strategies which act to both suppress COVID-19 outbreaks and relax restrictions when possible. We demonstrate that a controller that responds to the effective reproduction number in addition to case numbers is more efficient and effective in controlling new waves than monitoring case numbers alone. This not only reduces the median total infections and peak quarantine cases, but also controls outbreaks much more reliably: such a controller entirely prevents rare but large outbreaks. This is important as the majority of public discussions about efficient control of the epidemic have so far focused primarily on thresholds for case numbers. - 23 February 2022
- Published by Springer Nature
- p. 292-308
Impartial Predictive Modeling and the Use of Proxy Variables
- 23 February 2022
- Published by Springer Nature
- p. 292-308
Impartial Predictive Modeling and the Use of Proxy Variables
- Open Access
- 15 January 2022
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 145, 14-19
SARS-CoV-2 rapid antigen tests provide benefits for epidemic control – observations from Austrian schools
- 15 January 2022
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 145, 14-19
Open AccessSARS-CoV-2 rapid antigen tests provide benefits for epidemic control – observations from Austrian schools
- Open Access
Robust models of SARS-CoV-2 heterogeneity and control
In light of the continuing emergence of new SARS-CoV-2 variants and vaccines, we create a simulation framework for exploring possible infection trajectories under various scenarios. The situations of primary interest involve the interaction between three components: vaccination campaigns, non-pharmaceutical interventions (NPIs), and the emergence of new SARS-CoV-2 variants. Additionally, immunity waning and vaccine boosters are modeled to account for their growing importance. New infections are generated according to a hierarchical model in which people have a random, individual infectiousness. The model thus includes super-spreading observed in the COVID-19 pandemic. Our simulation functions as a dynamic compartment model in which an individual's history of infection, vaccination, and possible reinfection all play a role in their resistance to further infections. We present a risk measure for each SARS-CoV-2 variant, $\rho^\V$, that accounts for the amount of resistance within a population and show how this risk changes as the vaccination rate increases. Furthermore, by considering different population compositions in terms of previous infection and type of vaccination, we can learn about variants which pose differential risk to different countries. Different control strategies are implemented which aim to both suppress COVID-19 outbreaks when they occur as well as relax restrictions when possible. We demonstrate that a controller that responds to the effective reproduction number in addition to case numbers is more efficient and effective in controlling new waves than monitoring case numbers alone. This is of interest as the majority of the public discussion and well-known statistics deal primarily with case numbers.Open AccessRobust models of SARS-CoV-2 heterogeneity and control
In light of the continuing emergence of new SARS-CoV-2 variants and vaccines, we create a simulation framework for exploring possible infection trajectories under various scenarios. The situations of primary interest involve the interaction between three components: vaccination campaigns, non-pharmaceutical interventions (NPIs), and the emergence of new SARS-CoV-2 variants. Additionally, immunity waning and vaccine boosters are modeled to account for their growing importance. New infections are generated according to a hierarchical model in which people have a random, individual infectiousness. The model thus includes super-spreading observed in the COVID-19 pandemic. Our simulation functions as a dynamic compartment model in which an individual's history of infection, vaccination, and possible reinfection all play a role in their resistance to further infections. We present a risk measure for each SARS-CoV-2 variant, $\rho^\V$, that accounts for the amount of resistance within a population and show how this risk changes as the vaccination rate increases. Furthermore, by considering different population compositions in terms of previous infection and type of vaccination, we can learn about variants which pose differential risk to different countries. Different control strategies are implemented which aim to both suppress COVID-19 outbreaks when they occur as well as relax restrictions when possible. We demonstrate that a controller that responds to the effective reproduction number in addition to case numbers is more efficient and effective in controlling new waves than monitoring case numbers alone. This is of interest as the majority of the public discussion and well-known statistics deal primarily with case numbers. - Open Access
Impartial Predictive Modeling and the Use of Proxy Variables
Fairness aware data mining (FADM) aims to prevent algorithms from discriminating against protected groups. The literature has come to an impasse as to what constitutes explainable variability as opposed to discrimination. This distinction hinges on a rigorous understanding of the role of proxy variables; i.e., those variables which are associated both the protected feature and the outcome of interest. We demonstrate that fairness is achieved by ensuring impartiality with respect to sensitive characteristics and provide a framework for impartiality by accounting for different perspectives on the data generating process. In particular, fairness can only be precisely defined in a full-data scenario in which all covariates are observed. We then analyze how these models may be conservatively estimated via regression in partial-data settings. Decomposing the regression estimates provides insights into previously unexplored distinctions between explainable variability and discrimination that illuminate the use of proxy variables in fairness aware data mining.
Open AccessImpartial Predictive Modeling and the Use of Proxy Variables
Fairness aware data mining (FADM) aims to prevent algorithms from discriminating against protected groups. The literature has come to an impasse as to what constitutes explainable variability as opposed to discrimination. This distinction hinges on a rigorous understanding of the role of proxy variables; i.e., those variables which are associated both the protected feature and the outcome of interest. We demonstrate that fairness is achieved by ensuring impartiality with respect to sensitive characteristics and provide a framework for impartiality by accounting for different perspectives on the data generating process. In particular, fairness can only be precisely defined in a full-data scenario in which all covariates are observed. We then analyze how these models may be conservatively estimated via regression in partial-data settings. Decomposing the regression estimates provides insights into previously unexplored distinctions between explainable variability and discrimination that illuminate the use of proxy variables in fairness aware data mining.
- Open Access
Evidence suggests that SARS-CoV-2 rapid antigen tests provide benefits for epidemic control -- observations from Austrian schools
Rapid antigen tests detect proteins at the surface of virus particles, identifying the disease during its infectious phase. In contrast, PCR tests detect viral genomes; they can thus diagnose COVID-19 before the infectious phase but also react to remnants of the virus genome, even weeks after live virus ceases to be detectable in the respiratory tract. Furthermore, the logistics for administering the tests are different, with rapid antigen tests being much easier to administer at-scale. In this article, we discuss the relative advantages of the different testing procedures and summarise evidence that shows that using antigen tests 2-3 times per week could become a powerful tool to suppress the COVID-19 pandemic. We also discuss the results of recent large-scale rapid antigen testing in Austrian schools. While our report on testing predates Delta, we have updated the review with recent data on viral loads in breakthrough infections and more information about testing efficacy, especially in children.
Open AccessEvidence suggests that SARS-CoV-2 rapid antigen tests provide benefits for epidemic control -- observations from Austrian schools
Rapid antigen tests detect proteins at the surface of virus particles, identifying the disease during its infectious phase. In contrast, PCR tests detect viral genomes; they can thus diagnose COVID-19 before the infectious phase but also react to remnants of the virus genome, even weeks after live virus ceases to be detectable in the respiratory tract. Furthermore, the logistics for administering the tests are different, with rapid antigen tests being much easier to administer at-scale. In this article, we discuss the relative advantages of the different testing procedures and summarise evidence that shows that using antigen tests 2-3 times per week could become a powerful tool to suppress the COVID-19 pandemic. We also discuss the results of recent large-scale rapid antigen testing in Austrian schools. While our report on testing predates Delta, we have updated the review with recent data on viral loads in breakthrough infections and more information about testing efficacy, especially in children.
- Open Access
Disease Momentum: Estimating the Reproduction Number in the Presence of Superspreading
A primary quantity of interest in the study of infectious diseases is the average number of new infections that an infected person produces. This so-called reproduction number has significant implications for the disease progression. There has been increasing literature suggesting that superspreading, the significant variability in number of new infections caused by individuals, plays an important role in the spread of SARS-CoV-2. In this paper, we consider the effect that such superspreading has on the estimation of the reproduction number and subsequent estimates of future cases. Accordingly, we employ a simple extension to models currently used in the literature to estimate the reproduction number and present a case-study of the progression of COVID-19 in Austria. Our models demonstrate that the estimation uncertainty of the reproduction number increases with superspreading and that this improves the performance of prediction intervals. Of independent interest is the derivation of a transparent formula that connects the extent of superspreading to the width of credible intervals for the reproduction number. This serves as a valuable heuristic for understanding the uncertainty surrounding diseases with superspreading.
Open AccessDisease Momentum: Estimating the Reproduction Number in the Presence of Superspreading
A primary quantity of interest in the study of infectious diseases is the average number of new infections that an infected person produces. This so-called reproduction number has significant implications for the disease progression. There has been increasing literature suggesting that superspreading, the significant variability in number of new infections caused by individuals, plays an important role in the spread of SARS-CoV-2. In this paper, we consider the effect that such superspreading has on the estimation of the reproduction number and subsequent estimates of future cases. Accordingly, we employ a simple extension to models currently used in the literature to estimate the reproduction number and present a case-study of the progression of COVID-19 in Austria. Our models demonstrate that the estimation uncertainty of the reproduction number increases with superspreading and that this improves the performance of prediction intervals. Of independent interest is the derivation of a transparent formula that connects the extent of superspreading to the width of credible intervals for the reproduction number. This serves as a valuable heuristic for understanding the uncertainty surrounding diseases with superspreading.
- Open Access
- 1 January 2021
- Published by KEAI Publishing in Infectious Disease Modelling
- Vol. 6, 706-728
Disease momentum: Estimating the reproduction number in the presence of superspreading
A primary quantity of interest in the study of infectious diseases is the average number of new infections that an infected person produces. This so-called reproduction number has significant implications for the disease progression. There has been increasing literature suggesting that superspreading, the significant variability in number of new infections caused by individuals, plays an important role in the spread of SARS-CoV-2. In this paper, we consider the effect that such superspreading has on the estimation of the reproduction number and subsequent estimates of future cases. Accordingly, we employ a simple extension to models currently used in the literature to estimate the reproduction number and present a case-study of the progression of COVID-19 in Austria. Our models demonstrate that the estimation uncertainty of the reproduction number increases with superspreading and that this improves the performance of prediction intervals. Of independent interest is the derivation of a transparent formula that connects the extent of superspreading to the width of credible intervals for the reproduction number. This serves as a valuable heuristic for understanding the uncertainty surrounding diseases with superspreading.
- 1 January 2021
- Published by KEAI Publishing in Infectious Disease Modelling
- Vol. 6, 706-728
Open AccessDisease momentum: Estimating the reproduction number in the presence of superspreading
A primary quantity of interest in the study of infectious diseases is the average number of new infections that an infected person produces. This so-called reproduction number has significant implications for the disease progression. There has been increasing literature suggesting that superspreading, the significant variability in number of new infections caused by individuals, plays an important role in the spread of SARS-CoV-2. In this paper, we consider the effect that such superspreading has on the estimation of the reproduction number and subsequent estimates of future cases. Accordingly, we employ a simple extension to models currently used in the literature to estimate the reproduction number and present a case-study of the progression of COVID-19 in Austria. Our models demonstrate that the estimation uncertainty of the reproduction number increases with superspreading and that this improves the performance of prediction intervals. Of independent interest is the derivation of a transparent formula that connects the extent of superspreading to the width of credible intervals for the reproduction number. This serves as a valuable heuristic for understanding the uncertainty surrounding diseases with superspreading.
- Open Access
Fitting High-Dimensional Interaction Models with Error Control
There is a renewed interest in polynomial regression in the form of identifying influential interactions between features. In many settings, this takes place in a high-dimensional model, making the number of interactions unwieldy or computationally infeasible. Furthermore, it is difficult to analyze such spaces directly as they are often highly correlated. Standard feature selection issues remain such as how to determine a final model which generalizes well. This paper solves these problems with a sequential algorithm called Revisiting Alpha-Investing (RAI). RAI is motivated by the principle of marginality and searches the feature-space of higher-order interactions by greedily building upon lower-order terms. RAI controls a notion of false rejections and comes with a performance guarantee relative to the best-subset model. This ensures that signal is identified while providing a valid stopping criterion to prevent over-selection. We apply RAI in a novel setting over a family of regressions in order to select gene-specific interaction models for differential expression profiling.
Open AccessFitting High-Dimensional Interaction Models with Error Control
There is a renewed interest in polynomial regression in the form of identifying influential interactions between features. In many settings, this takes place in a high-dimensional model, making the number of interactions unwieldy or computationally infeasible. Furthermore, it is difficult to analyze such spaces directly as they are often highly correlated. Standard feature selection issues remain such as how to determine a final model which generalizes well. This paper solves these problems with a sequential algorithm called Revisiting Alpha-Investing (RAI). RAI is motivated by the principle of marginality and searches the feature-space of higher-order interactions by greedily building upon lower-order terms. RAI controls a notion of false rejections and comes with a performance guarantee relative to the best-subset model. This ensures that signal is identified while providing a valid stopping criterion to prevent over-selection. We apply RAI in a novel setting over a family of regressions in order to select gene-specific interaction models for differential expression profiling.